FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TAZEMETOSTAT HYDROBROMIDE
异名/同义词(1,1'-BIPHENYL)-3-CARBOXAMIDE, N-((1,2-DIHYDRO-4,6-DIMETHYL-2-OXO-3-PYRIDINYL)METHYL)-5-(ETHYL(TETRAHYDRO-2H-PYRAN-4-YL)AMINO)-4-METHYL-4'-(4-MORPHOLINYLMETHYL)-, HYDROBROMIDE (1:1)
E-7438 HYDROBROMIDE
EPZ-6438 MONOHYDROBROMIDE
EZ438
EZ-438
N-((4,6-DIMETHYL-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL)-5-(ETHYL(OXAN-4-YL)AMINO)-4-METHYL-4'-((MORPHOLIN-4-YL)METHYL)(1,1'-BIPHENYL)-3-CARBOXAMIDE MONOHYDROBROMIDE
TAZEMETOSTAT HYDROBROMIDE
TAZEMETOSTAT HYDROBROMIDE [JAN]
TAZEMETOSTAT HYDROBROMIDE [ORANGE BOOK]
TAZEMETOSTAT HYDROBROMIDE [USAN]
TAZEMETOSTAT HYDROBROMIDE [WHO-DD]
TAZEMETOSTAT MONOHYDROBROMIDE
TAZVERIK
CAS登记号1467052-75-0
物质唯一标识(Unique Ingredient Identifier)6P89T5M073
分子式
国际化合物标识(International Chemical Identifier,InChI)FG-163
SMILESC34H44N4O4.BrH
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型UQRICAQPWZSJNF-UHFFFAOYSA-N / Br.N(C1CCOCC1)(c2cc(-c3ccc(CN4CCOCC4)cc3)cc(C(=O)NCc5c(=O)[nH]c(C)cc5C)c2C)CC
关联数据
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System